SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-17-340894
Filing Date
2017-11-13
Accepted
2017-11-13 16:11:07
Documents
2
Group Members
MAK LLCMEH ACQUISITION CO.

Document Format Files

Seq Description Document Type Size
1 SC 13D d415102dsc13d.htm SC 13D 105909
2 EX-99.3 d415102dex993.htm EX-99.3 5926
  Complete submission text file 0001193125-17-340894.txt   113585
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065 6504750158
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86177 | Film No.: 171195948
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Filed by) CIK: 0001567892 (see all company filings)

IRS No.: 981088325 | Fiscal Year End: 1229
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations